Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO) (HB823016)

Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HB823016
Description
Anifrolumab (HB823016) is a research-grade recombinant antibody targeting Interferon alpha/beta receptor 1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHuman
IsotypeIgG1-kappa
Expression system Mammalian cells
Clonality Monoclonal
Target Interferon alpha/beta receptor 1, Cytokine receptor family 2 member 1, Cytokine receptor class-II member 1, CRF2-1, IFN-R-1, IFNAR1, IFNAR, IFN-alpha/beta receptor 1, Type I interferon receptor 1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P17181
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesMDX-1333, MEDI-546, 1326232-46-5
Background

Interferon alpha/beta receptor 1 (IFNAR1) is a ~63 kDa protein. Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response. Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another. The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors. STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes.

1. Russell-Harde, D. et al. (1999) Biochemical and biophysical research communications 255, 539-44. PMID: 10049744
2. Kumar, KG. et al. (2003) The EMBO journal 22, 5480-90. PMID: 14532120
3. Kumar, KG. et al. (2004) The Journal of biological chemistry 279, 46614-20. PMID: 15337770
4. Uzé, G. et al. (1990) Cell 60, 225-34. PMID: 2153461
5. Thomas, C. et al. (2011) Cell 146, 621-32. PMID: 21854986
6. Zheng, H. et al. (2013) Cell reports 5, 180-93. PMID: 24075985
7. Hernandez, N. et al. (2019) The Journal of experimental medicine 216, 2057-2070. PMID: 31270247
8. Gothe, F. et al. (2022) Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74, 136-139. PMID: 33252644
9. Bastard, P. et al. (2022) The Journal of experimental medicine 219. PMID: 35442418
10. Abramovich, C. et al. (1994) The EMBO journal 13, 5871-7. PMID: 7813427
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Anifrolumab.

  • Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Anifrolumab.

  • Anti-Human IFN-alpha/beta R1 Reference Antibody (Anifrolumab, RUO)

    Western blot

    Western blot analysis was performed using anti-IFNAR1 monoclonal antibody at 1μg/ml on various samples.
    Lane 1: recombinant human IFNAR1 (Catalog No: HB823011), 50ng
    Lane 2: recombinant human IFNAR1 (Catalog No: HB823011), 30ng
    Lane 3: recombinant human IFNAR1 (Catalog No: HB823011), 20ng

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list